Coloplast As Sp/Adr (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 140,251 | 114,575 | 130,637 | 60,361 | 71,994 |
| Marketable Securities | N/A | N/A | N/A | 31,930 | 36,318 |
| Receivables | 766,566 | 806,970 | 734,208 | 679,282 | 597,804 |
| Inventories | 580,404 | 533,909 | 505,055 | 464,665 | 390,180 |
| TOTAL | $1,548,089 | $1,518,558 | $1,424,966 | $1,278,958 | $1,123,936 |
| Non-Current Assets | |||||
| PPE Net | 918,368 | 821,365 | 735,785 | 652,309 | 608,250 |
| Investments And Advances | 13,329 | 10,760 | 9,321 | 7,436 | 6,589 |
| Intangibles | 4,461,809 | 4,410,273 | 4,481,967 | 2,956,387 | 586,716 |
| Other Non-Current Assets | 221,557 | 228,859 | 253,962 | 201,495 | 220,159 |
| TOTAL | $5,615,063 | $5,471,256 | $5,481,035 | $3,817,627 | $1,421,713 |
| Total Assets | $7,163,153 | $6,989,814 | $6,906,000 | $5,096,585 | $2,545,649 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 695,060 | N/A | N/A |
| Accounts payable and accrued liabilities | 548,859 | 573,458 | 651,466 | 551,999 | 462,173 |
| Other current liabilities | 353,663 | 747,501 | 353,051 | 291,454 | 374,913 |
| TOTAL | $963,391 | $1,483,662 | $2,338,997 | $1,069,589 | $1,014,660 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,866,179 | 2,407,388 | 1,657,417 | 2,385,142 | N/A |
| Other Non-Current Liabilities | 945,915 | 489,998 | 428,910 | 432,880 | 218,391 |
| TOTAL | $3,812,094 | $2,897,386 | $2,086,327 | $2,818,022 | $218,391 |
| Total Liabilities | $4,775,484 | $4,381,047 | $4,425,324 | $3,887,611 | $1,233,051 |
| Shareholders' Equity | |||||
| Common Shares | 33,767 | 33,151 | 32,695 | 31,493 | 34,711 |
| Retained earnings | 2,016,826 | 2,237,851 | 2,098,229 | 785,279 | 868,744 |
| Other shareholders' equity | 337,075 | 337,765 | 349,753 | 392,202 | 409,143 |
| TOTAL | $2,387,668 | $2,608,767 | $2,480,677 | $1,208,974 | $1,312,598 |
| Total Liabilities And Equity | $7,163,152 | $6,989,814 | $6,906,001 | $5,096,585 | $2,545,649 |